Results 81 to 90 of about 7,279 (128)

Comparison of surgical safety among different comprehensive treatment models for adenocarcinoma of esophagogastric junction: a single-center cohort study. [PDF]

BMC Gastroenterol
Dai H, Wang Y, Shan F, Li S, Jia Y, Xue K, Miao R, Li Z, Xiu X, Li Z, Ji J.   +10 more
europepmc   +1 more source

Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery. [PDF]

Cancer Manag Res, 2020
Zheng C, Feng X, Zheng J, Yan Q, Hu X, Feng H, Deng Z, Liao Q, Wang J, Li Y.   +9 more
europepmc   +1 more source

Impact of prior cancer history on survival in patients with adenocarcinoma of esophagogastric junction: a retrospective cohort study using SEER database. [PDF]

Transl Cancer Res
Lai H, Zhou J, Zheng J, Feng H, Cao L, Hou B, Li Y.   +6 more
europepmc   +1 more source

Neoadjuvant adebrelimab combined with triplet chemotherapy for locally advanced resectable adenocarcinoma of esophagogastric junction: a prospective, single-arm, phase II feasibility and safety study. [PDF]

J Gastrointest Oncol
Liu J, Zhang R, Zhou W, Li Z, Zhang G, Yang L, Fan A, Liu S, Miao Y, Sun H, Hong L, Wang M.   +11 more
europepmc   +1 more source

Clinical application value of modified overlap anastomosis for Siewert type II and III adenocarcinoma of esophagogastric junction. [PDF]

J Cancer Res Clin Oncol
Fan Y, Hou L, Zhang H, Zhang R, Shi G, Li Q, Wang X, Wang Y, Wei Q, Gao T.   +9 more
europepmc   +1 more source

The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction. [PDF]

Cancer Manag Res, 2020
Wang Y, Wang S, Zhu C, Cao H, Zhang Z, Zhao E.   +5 more
europepmc   +1 more source

Involvement of long non-coding RNA NORAD in short-term poor prognosis of neoadjuvant chemotherapy in adenocarcinoma of esophagogastric junction. [PDF]

Ann Med
Li S, Liu J, Nie Z, Li H, Wang J.
europepmc   +1 more source

The length of negative proximal resection margin does not significantly influence on the prognosis of Siewert type II adenocarcinoma of esophagogastric junction with or without neoadjuvant chemotherapy. [PDF]

Front Oncol
Yao Z, Liu M, Tan F, Cui M, Xing J, Zhang C, Yang H, Chen L, Xu K, Su X.   +9 more
europepmc   +1 more source

Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study. [PDF]

BMC Surg, 2020
Feng Y, Jiang Y, Zhao Q, Liu J, Zhang H, Chen Q.   +5 more
europepmc   +1 more source

Investigating the Effects of Different Lengths of Proximal Margin for Siewert Type II and Type III Adenocarcinoma of Esophagogastric Junction on Short- and Long-Term Prognosis. [PDF]

Cancer Manag Res
Liu G, Hao C, Zhang Y, Qi S, Li F, Bian J, Zhang C, Liu W.   +7 more
europepmc   +1 more source